JOHNSON & JOHNSON (1JNJ.MI) Fundamental Analysis & Valuation

BIT:1JNJ • US4781601046

Current stock price

212.65 EUR
+4.2 (+2.01%)
Last:

This 1JNJ.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 1JNJ.MI Profitability Analysis

1.1 Basic Checks

  • 1JNJ had positive earnings in the past year.
  • 1JNJ had a positive operating cash flow in the past year.
  • 1JNJ had positive earnings in each of the past 5 years.
  • In the past 5 years 1JNJ always reported a positive cash flow from operatings.
1JNJ.MI Yearly Net Income VS EBIT VS OCF VS FCF1JNJ.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

1.2 Ratios

  • 1JNJ has a Return On Assets of 13.46%. This is amongst the best in the industry. 1JNJ outperforms 86.27% of its industry peers.
  • Looking at the Return On Equity, with a value of 32.87%, 1JNJ is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 14.37%, 1JNJ is doing good in the industry, outperforming 70.59% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for 1JNJ is in line with the industry average of 17.40%.
Industry RankSector Rank
ROA 13.46%
ROE 32.87%
ROIC 14.37%
ROA(3y)14.08%
ROA(5y)12.66%
ROE(3y)34.55%
ROE(5y)31.04%
ROIC(3y)16.34%
ROIC(5y)15%
1JNJ.MI Yearly ROA, ROE, ROIC1JNJ.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • 1JNJ's Profit Margin of 28.46% is amongst the best of the industry. 1JNJ outperforms 90.20% of its industry peers.
  • 1JNJ's Profit Margin has improved in the last couple of years.
  • The Operating Margin of 1JNJ (27.78%) is better than 70.59% of its industry peers.
  • In the last couple of years the Operating Margin of 1JNJ has grown nicely.
  • 1JNJ has a Gross Margin (67.92%) which is comparable to the rest of the industry.
  • 1JNJ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.78%
PM (TTM) 28.46%
GM 67.92%
OM growth 3Y6.15%
OM growth 5Y6.99%
PM growth 3Y8.26%
PM growth 5Y9.82%
GM growth 3Y-0.67%
GM growth 5Y0.65%
1JNJ.MI Yearly Profit, Operating, Gross Margins1JNJ.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. 1JNJ.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1JNJ is creating some value.
  • Compared to 1 year ago, 1JNJ has about the same amount of shares outstanding.
  • 1JNJ has less shares outstanding than it did 5 years ago.
  • 1JNJ has a worse debt/assets ratio than last year.
1JNJ.MI Yearly Shares Outstanding1JNJ.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
1JNJ.MI Yearly Total Debt VS Total Assets1JNJ.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • An Altman-Z score of 5.11 indicates that 1JNJ is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 5.11, 1JNJ is doing good in the industry, outperforming 76.47% of the companies in the same industry.
  • 1JNJ has a debt to FCF ratio of 2.43. This is a good value and a sign of high solvency as 1JNJ would need 2.43 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 2.43, 1JNJ is doing good in the industry, outperforming 72.55% of the companies in the same industry.
  • 1JNJ has a Debt/Equity ratio of 0.56. This is a neutral value indicating 1JNJ is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.56, 1JNJ perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
  • Even though the debt/equity ratio score it not favorable for 1JNJ, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.43
Altman-Z 5.11
ROIC/WACC1.52
WACC9.45%
1JNJ.MI Yearly LT Debt VS Equity VS FCF1JNJ.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that 1JNJ should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.03, 1JNJ is not doing good in the industry: 72.55% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.77 indicates that 1JNJ may have some problems paying its short term obligations.
  • 1JNJ has a worse Quick ratio (0.77) than 74.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.77
1JNJ.MI Yearly Current Assets VS Current Liabilites1JNJ.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

5

3. 1JNJ.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 8.11% over the past year.
  • The Earnings Per Share has been growing slightly by 6.11% on average over the past years.
  • 1JNJ shows a small growth in Revenue. In the last year, the Revenue has grown by 6.05%.
  • The Revenue has been growing slightly by 2.67% on average over the past years.
EPS 1Y (TTM)8.11%
EPS 3Y2.06%
EPS 5Y6.11%
EPS Q2Q%20.59%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y5.6%
Revenue growth 5Y2.67%
Sales Q2Q%9.08%

3.2 Future

  • Based on estimates for the next years, 1JNJ will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.75% on average per year.
  • Based on estimates for the next years, 1JNJ will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y7.85%
EPS Next 2Y8.27%
EPS Next 3Y8.5%
EPS Next 5Y8.75%
Revenue Next Year7.24%
Revenue Next 2Y6.55%
Revenue Next 3Y6.35%
Revenue Next 5Y6.02%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1JNJ.MI Yearly Revenue VS Estimates1JNJ.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
1JNJ.MI Yearly EPS VS Estimates1JNJ.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

2

4. 1JNJ.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 22.69, 1JNJ is valued on the expensive side.
  • 1JNJ's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.17, 1JNJ is valued at the same level.
  • The Price/Forward Earnings ratio is 21.04, which indicates a rather expensive current valuation of 1JNJ.
  • 1JNJ's Price/Forward Earnings ratio is in line with the industry average.
  • 1JNJ is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.69
Fwd PE 21.04
1JNJ.MI Price Earnings VS Forward Price Earnings1JNJ.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1JNJ is on the same level as its industry peers.
  • 60.78% of the companies in the same industry are cheaper than 1JNJ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 29.97
EV/EBITDA 17.85
1JNJ.MI Per share data1JNJ.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1JNJ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.89
PEG (5Y)3.72
EPS Next 2Y8.27%
EPS Next 3Y8.5%

5

5. 1JNJ.MI Dividend Analysis

5.1 Amount

  • 1JNJ has a Yearly Dividend Yield of 2.16%. Purely for dividend investing, there may be better candidates out there.
  • 1JNJ's Dividend Yield is a higher than the industry average which is at 1.94.
  • Compared to an average S&P500 Dividend Yield of 1.89, 1JNJ has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

  • The dividend of 1JNJ is nicely growing with an annual growth rate of 7.68%!
Dividend Growth(5Y)7.68%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 46.19% of the earnings are spent on dividend by 1JNJ. This is a bit on the high side, but may be sustainable.
  • 1JNJ's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP46.19%
EPS Next 2Y8.27%
EPS Next 3Y8.5%
1JNJ.MI Yearly Income VS Free CF VS Dividend1JNJ.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B
1JNJ.MI Dividend Payout.1JNJ.MI Dividend Payout, showing the Payout Ratio.1JNJ.MI Dividend Payout.PayoutRetained Earnings

1JNJ.MI Fundamentals: All Metrics, Ratios and Statistics

JOHNSON & JOHNSON

BIT:1JNJ (4/2/2026, 7:00:00 PM)

212.65

+4.2 (+2.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-21
Earnings (Next)04-14
Inst Owners75.62%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap512.19B
Revenue(TTM)94.19B
Net Income(TTM)26.80B
Analysts76.25
Price Target197.11 (-7.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend4.46
Dividend Growth(5Y)7.68%
DP46.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-0.13%
Max EPS beat(2)0.55%
EPS beat(4)3
Avg EPS beat(4)2.17%
Min EPS beat(4)-0.13%
Max EPS beat(4)5.96%
EPS beat(8)7
Avg EPS beat(8)2.84%
EPS beat(12)10
Avg EPS beat(12)3.23%
EPS beat(16)14
Avg EPS beat(16)3.09%
Revenue beat(2)2
Avg Revenue beat(2)0.35%
Min Revenue beat(2)0.03%
Max Revenue beat(2)0.67%
Revenue beat(4)4
Avg Revenue beat(4)1.04%
Min Revenue beat(4)0.03%
Max Revenue beat(4)2.92%
Revenue beat(8)5
Avg Revenue beat(8)0.32%
Revenue beat(12)8
Avg Revenue beat(12)-0.5%
Revenue beat(16)8
Avg Revenue beat(16)-4.44%
PT rev (1m)0%
PT rev (3m)7.31%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)-3.08%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-0.08%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)1.89%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)1.83%
Valuation
Industry RankSector Rank
PE 22.69
Fwd PE 21.04
P/S 6.27
P/FCF 29.97
P/OCF 24.06
P/B 7.24
P/tB N/A
EV/EBITDA 17.85
EPS(TTM)9.37
EY4.41%
EPS(NY)10.11
Fwd EY4.75%
FCF(TTM)7.1
FCFY3.34%
OCF(TTM)8.84
OCFY4.16%
SpS33.93
BVpS29.38
TBVpS-6.35
PEG (NY)2.89
PEG (5Y)3.72
Graham Number78.7
Profitability
Industry RankSector Rank
ROA 13.46%
ROE 32.87%
ROCE 18.03%
ROIC 14.37%
ROICexc 16.57%
ROICexgc 67.45%
OM 27.78%
PM (TTM) 28.46%
GM 67.92%
FCFM 20.91%
ROA(3y)14.08%
ROA(5y)12.66%
ROE(3y)34.55%
ROE(5y)31.04%
ROIC(3y)16.34%
ROIC(5y)15%
ROICexc(3y)19.6%
ROICexc(5y)18.23%
ROICexgc(3y)74.51%
ROICexgc(5y)73.44%
ROCE(3y)20.24%
ROCE(5y)18.7%
ROICexgc growth 3Y3.9%
ROICexgc growth 5Y-2.01%
ROICexc growth 3Y8.52%
ROICexc growth 5Y5.62%
OM growth 3Y6.15%
OM growth 5Y6.99%
PM growth 3Y8.26%
PM growth 5Y9.82%
GM growth 3Y-0.67%
GM growth 5Y0.65%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.43
Debt/EBITDA 1.36
Cap/Depr 64.4%
Cap/Sales 5.13%
Interest Coverage 6.81
Cash Conversion 72.86%
Profit Quality 73.49%
Current Ratio 1.03
Quick Ratio 0.77
Altman-Z 5.11
F-Score4
WACC9.45%
ROIC/WACC1.52
Cap/Depr(3y)61.79%
Cap/Depr(5y)58.46%
Cap/Sales(3y)5.15%
Cap/Sales(5y)5.02%
Profit Quality(3y)88.82%
Profit Quality(5y)91.38%
High Growth Momentum
Growth
EPS 1Y (TTM)8.11%
EPS 3Y2.06%
EPS 5Y6.11%
EPS Q2Q%20.59%
EPS Next Y7.85%
EPS Next 2Y8.27%
EPS Next 3Y8.5%
EPS Next 5Y8.75%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y5.6%
Revenue growth 5Y2.67%
Sales Q2Q%9.08%
Revenue Next Year7.24%
Revenue Next 2Y6.55%
Revenue Next 3Y6.35%
Revenue Next 5Y6.02%
EBIT growth 1Y12.82%
EBIT growth 3Y12.1%
EBIT growth 5Y9.84%
EBIT Next Year23.18%
EBIT Next 3Y11.51%
EBIT Next 5Y8.55%
FCF growth 1Y-0.73%
FCF growth 3Y4.65%
FCF growth 5Y-0.49%
OCF growth 1Y1.09%
OCF growth 3Y4.99%
OCF growth 5Y0.83%

JOHNSON & JOHNSON / 1JNJ.MI Fundamental Analysis FAQ

What is the fundamental rating for 1JNJ stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1JNJ.MI.


What is the valuation status for 1JNJ stock?

ChartMill assigns a valuation rating of 2 / 10 to JOHNSON & JOHNSON (1JNJ.MI). This can be considered as Overvalued.


How profitable is JOHNSON & JOHNSON (1JNJ.MI) stock?

JOHNSON & JOHNSON (1JNJ.MI) has a profitability rating of 7 / 10.


What is the expected EPS growth for JOHNSON & JOHNSON (1JNJ.MI) stock?

The Earnings per Share (EPS) of JOHNSON & JOHNSON (1JNJ.MI) is expected to grow by 7.85% in the next year.


How sustainable is the dividend of JOHNSON & JOHNSON (1JNJ.MI) stock?

The dividend rating of JOHNSON & JOHNSON (1JNJ.MI) is 5 / 10 and the dividend payout ratio is 46.19%.